Danny Jones Podcast #374: Ex-Pharma Insider Exposes the $368 Billion Health Insurance Scam | Brigham Buhler
Date: February 27, 2026
Guest: Brigham Buhler (Founder, Ways2Well; Ex-Pharma, Med Device & Pharmacy Insider)

Episode Overview

In this episode, Danny Jones sits down with Brigham Buhler, a former pharmaceutical and medical device insider turned health entrepreneur and whistleblower. Brigham shares a firsthand, unfiltered exposé of America’s $368 billion health insurance scam, explaining how insurance companies, pharmacy benefit managers, Big Pharma, and hospital systems collaborate to keep patients sick, confused, and dependent on prescription drugs. Brigham also describes his journey stepping outside the insurance model to create affordable, preventative-focused healthcare options. The discussion covers industry corruption, prescription drug practices, FDA failings, medical education, patient empowerment, and cutting-edge advances in peptides and stem cell therapies.

1. Brigham’s Origin Story: From Pharma to Whistleblower

[00:27–07:20]

• Early Aspirations vs. Reality:
  • Brigham started as a drug rep for Eli Lilly, launching Cialis at age 20. He believed he was helping people, “going to educate doctors on cutting edge treatments and we’re going to change the world.”
  • Quickly disillusioned: “That’s not at all what that was... I figured it out pretty quick for a kid. This isn’t going to work for me.”
• Medical Device Experience:
  • Nearly a decade among top surgeons gave him “a look behind the curtain at the intricate network” of hospitals, insurers, and industry collusion.
• Personal Tragedy:
  • Loss of his brother to the opioid crisis led Brigham to open a pharmacy focused on non-addictive alternatives.
• Realization and Reinvention:
  • Couldn’t survive in the insurance model: “I saw the ship was sinking and I knew the only way to fix this was to build a life raft... to get proactive, predictive, and preventative.”

2. Anatomy of the Health Insurance Scam

[10:04–25:29]

• Pharmacy Game:
  • Patients think insurance helps, but it often costs more than cash. “There’s a gag clause… legally, I’m not allowed to tell your grandma that her cash price is $2 [for metformin]… I have to collect a $10 copay instead. I don’t get that extra $9 – the insurance company does.” [09:00]
• PBMs and Artificial Costs:
  • Pharmacy Benefit Managers (PBMs) control drug pricing and coverage, often raising prices through convoluted rebate schemes that enrich insurers, not patients.
  • “[PBMs] were supposed to negotiate drug prices down. Instead, after being acquired by insurance companies, they negotiate them up.” [23:30]
• Rebate Shell Game:
  • Example: Insulin is shown as a $600 monthly cost. PBM “negotiates” a $300 rebate to itself, so the insurance company pockets the difference, while showing employers (who actually pay the bills) the full price. [25:29]
• Rampant Industry Collusion:
  • Five insurance conglomerates dominate 90% of employer-based insurance, controlling primary care, PBMs, and even direct providers—creating a closed, profit-driven system.
• Physician Constraints:
  • Primary care doctors are forced to see 40+ patients/day (average 6 minutes each), leaving no time for prevention or diagnostics.
  • “The system’s not built to prevent, it’s built to monetize and profiteer off chronic disease.” [03:50]
• Sick-Care, Not Healthcare:
  • “You have insurance, you trust the system, you’re going to be taken care of. It’s unfortunate, because don’t be surprised when you die of the average chronic disease.”

Memorable Quote:

“The problem isn’t the fish, it’s the tank... At some point you have to ask yourself, what is in the water? We’ve got to drain the tank.” [08:16]

3. Prescription Drug Culture and the Origins of Overmedication

[11:20–19:53]

• Marketing Medicine:
  • Reps target high-prescribing clinicians. Brigham: “My manager would say, you go find that person and become their best fucking friend… we need to sell more antidepressants.” [12:15]
• Fraudulent Disease Models:
  • Depression/SSRI story: “Never been a single study, never been a single autopsy… that shows antidepressants work at a chemical level [on serotonin].” Placebo was nearly as effective as Prozac. [13:20]
  • “Exercise and sleep outperform antidepressants… But prescription rates keep climbing because the SSRIs are embedded in medical training.”
• Perverse Incentives:
  • Doctors don’t get direct kickbacks but become “captured” by system protocols, company-sponsored education, and easy-to-prescribe, insured drugs.
  • “The average American is on four or more prescription drugs.” [16:00]

4. Denial and Obstruction: How Insurance Blocks Care

[20:37–27:45]

• Prevention Denied:
  • “As soon as clinicians try to pull comprehensive bloodwork, insurance threatens to terminate the contract.” [20:37]
• Systemic Cost Avoidance:
  • “Executives know preventing diabetes would save money, but most Americans change employers every 2.5 years, so the cost lands on someone else. The insurer’s focus is their quarterly profit, not health outcomes.”
• Obstruction Tactics:
  • “Delay, deny, depose.” Make care inaccessible, wear patients down until they give up. “The margins are made in the mystery.”
  • Hospitals and insurers bundle vaccine purchases, rewarding doctors for compliance, not outcomes.

Memorable Quote:

“If you fill a compounded GLP-1 for $200 cash, guess who’s not making the 30% rebate? Your insurance company… The whole system is built to hit quarterly earnings, not get proactive, predictive, or preventative.” [58:20]

5. FDA, Pharma, and Regulatory Capture

[41:46–71:36]

• FDA Approval Illusion:
  • 92% of surgical products in US have never had human safety studies—slipped through under “510k equivalence.” [62:00]
  • “60–80% of new drugs approved by FDA will have a major recall or label change.” [67:28]
  • Massive conflicts of interest: “90% of FDA commissioners have gone to work for the industries they regulate.” [71:36]
• Opioid Crisis:
  • Purdue Pharma lobbied FDA, misrepresented OxyContin’s addictiveness, and PBMs profited off every prescription.
• Suppression of Preventatives:
  • Insurance will not cover non-addictive alternatives or comprehensive lab work, because the profit is in chronic illness and recurrent drug sales.
• Failed Oversight:
  • FDA bans, then black-markets peptides and stem cells, pushing people to unregulated sources and stoking more harm. “Four out of five peptides filled in America are from gray or black market today.” [115:20–119:00]

6. The Pediatric Vaccine Incentive Structure

[72:18–81:10]

• Corporate-Owned Pediatricians:
  • Hospital systems mass-purchase vaccines, incentivize doctors by compliance rates (i.e., revenue bonuses).
  • “I’m helping states sue these institutions. We have whistleblowers and all of this to prove it.”
• Mandates & Evolving Schedules:
  • Schedule keeps growing (over 70 vaccines by age 6). Doctors are “brainwashed by the system,” not evil—just following protocol [75:49].
• Parental Choice and Recent Reforms:
  • Discussion on Bobby Kennedy’s efforts to restore medical freedom: “Secretary Kennedy has been able to fix the vaccine schedule and bring it back to the right to choose. If you want to vaccinate your child, vaccinate your child. All he’s done is provide a pathway for people to have what option they think is best for them in their personal situation.” [88:00]

7. Attempts to Reform: Cash Pay, Patient Empowerment, & Political Testimony

[46:07, 108:47–117:15]

• “Building a Life Raft”:
  • Brigham’s solutions: cash-pay pharmacies, affordable bloodwork, mobile phlebotomy, app-based AI analytics—a model now (finally) proliferating post-Covid as public trust in the system eroded.
• Testifying for Change:
  • Describes his collaboration with Bobby Kennedy, congressional testimony with the “Maha movement,” and legislative efforts to legalize and regulate peptides, stem cells.
  • Cites first-hand lobbying/industry retaliation:
    • “Merchant company shut off all our credit cards days before Rogan… $400,000 locked up. Social media bans. Lawsuits from Eli Lilly for making compounded GLP1s when the FDA asked us to fill the gap. It’s dark.” [51:24, 56:00]
• Industry Backlash & Political Reality:
  • Pharma, insurance, and regulatory agencies defend their territory through lawsuits, bank/billing pressures, lobbying, and manipulating government and media.
  • Cynicism about progress sustaining past the current reformist, citizen-powered administration.

8. Root Cause Medicine and Proper Prevention

[28:32, 49:30, 94:33–104:33]

• Cash-Pay Clinics vs. Industrialized Primary Care:
  • “We spend 45 minutes with each patient, do comprehensive panels, DEXA, VO2 max, all to model out chronic disease risk and actually prevent it. You can’t do that in the insurance-based world.”
• Empowering Through Data:
  • Will accept any lab work from anywhere. The goal: “Distill it down, empower the patient, put the power in the patient’s pocket.”
• Notable Stories:
  • “When Jay (Jelly Roll) came in, we focused on hormone optimization, bloodwork, and lifestyle. No GLP-1 needed for him to lose weight—it was about getting his testosterone, estrogen, and insulin right. He did the rest with discipline.”
• Rational GLP-1 & Peptide Usage:
  • “GLP-1s are a tool, not a panacea. For right patients, they work, but always as part of a broader plan, not a quick fix.”

Memorable Quote:

“Taking a GLP1 without talking about diet, lifestyle, nutrition is like brushing your teeth while eating fucking Oreos.” [99:00]

9. FDA, Peptides, and the Turf War Over New Therapies

[53:41–60:26, 115:20–127:49]

• Peptide Legislation Battles:
  • 19 blockbuster peptides banned by FDA (GLP-1s, BPC-157, etc.) at behest of pharma lobbying; FOIA requests for safety data denied.
  • “All the rhetoric is marketing and spin. They own the media, fund the narrative, control the message.”
• Fight for Fair Regulation:
  • Brigham pushes for regulatory frameworks that allow patients to choose cash-pay, off-label therapies with physicians as guides.
  • “If you really want to drive down the cost, you go cash pay and you continue to scale... patient sovereignty and autonomy over their health.”

10. The Food Industry, Schools, and Public Health Policy

[129:34–132:32]

• US vs. Europe:
  • Higher glyphosate, processed food ingredients, and loose food standards in the USA compared to Europe or Canada; this is regulatory and economic, not necessity.
  • Policy changes on food stamps, school nutrition, and food pyramids under the current administration are signs of positive movement.

11. Stem Cell and Genetic Frontiers: The Next Evolution

[136:11–157:15]

• Stem Cell Revolution:
  • Brigham describes advances, incl. "Muse" super-stem cells (from Japan), which are ultra-resilient, non-tumorigenic, persist in the body, and can meaningfully heal tissues—even demonstrate dramatic results in Alzheimer’s and chronic diseases.
• Success Stories:
  • Wheelchair-bound patients walking again, improved Alzheimer’s symptoms, regulatory reform efforts to give patients the right to choose.
• Gene Activation and “X-Men Medicine”:
  • Describes meeting a DOD geneticist with tech to make bone density “eight times stronger,” or enhance muscle growth, or cognitive capacities (Klotho gene). “The future’s gonna get wild. Peptides are child’s play compared to what’s coming.” [153:57]

12. Psychedelics, Big Money, and Medical Ethics

[157:14–166:17]

• Military and Psilocybin:
  • DARPA-backed efforts to use psychedelics for soldiers’ trauma and performance.
• Billionaire Funding Wars:
  • Backroom intrigue and rivalry around FDA approvals for MDMA and psilocybin, with financial and ego stakes influencing scientific direction.
• Potential and Pitfalls:
  • Acknowledges that while psychedelics and innovative medicine can be transformative, evangelism and profiteering can distort their healing potential.
• Evangelist and Messiah Complexes:
  • Cautions about the unintended consequences and human complexities in any new treatment trend.

Notable Quotes

• On systemic failure:

  “If what we were doing for the last 20 years worked, then why are we more sick than ever, more diabetic than ever, more riddled with cancer than ever, more depressed than ever, more suicides than ever, more deaths of despair than ever? Your system is not working. The emperor wears no clothes.” [93:29]

• On FDA capture:

  “90% of the commissioners of the FDA have gone to work for the very industries that they’re supposed to regulate.” [71:36]

• On prevention:

  “You don’t expect the insurance company to rotate the tires or change the oil. You take autonomy and sovereignty over that… Stop fucking putting your body at risk in the hands of these scumbags.” [32:54]

• On new tech:

  “We are living in the era of X-Men. I can build X-Men today.” [153:23]

13. Final Thoughts & Takeaways

[168:33–End]

• Call to Action:
  • Brigham urges listeners to pursue “proactive, predictive, and preventative” healthcare, using all available information and technology to take charge of their own well-being.
  • “Don’t put your health in the hands of this broken-ass system—be a steward to yourself and your family. The future’s bright.”
• Learn More:
  • Brigham’s practice: ways2well.com

Useful Timestamps (summary level)

• 00:49 – Brigham’s pharma beginnings and industry disillusionment
• 09:00 – How insurance pricing and PBMs rip off patients
• 13:20 – The SSRI/antidepressant fraud (placebo nearly as strong)
• 20:37 – How insurers block true diagnostic and prevention work
• 25:29 – How PBMs, insurers, pharma collaborate to inflate costs
• 41:46 – FDA’s failings, approval mirages, industry revolving door
• 53:41 – Ban on peptides, lawsuit battles, industry retaliation
• 79:33 – Parental choice, RFK, and the pediatric vaccine debate
• 108:47 – Political testifying, Senate appearances, regulatory change
• 136:11 – Stem cells, MUSE, and the bleeding edge of therapy
• 153:00 – Gene editing, “X-Men medicine,” and what’s next
• 157:15 – Psychedelics as medicine: progress and pitfalls
• 168:33 – Closing: how to take charge of your health

Tone & Style

• Brigham: Passionate, blunt, often explicit in his condemnation of corporate medicine and regulatory failures; equally optimistic and practical about possibilities for reform via patient empowerment and new technology.
• Danny: Curious, open-minded, occasionally incredulous, focused on clarifying for listeners who may be new to these systems.

This summary omits advertisements, intros, and outros. For in-depth listening, refer to timestamps above.